Loading…

Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus

Vancomycin (VAN) minimum inhibitory concentrations (MICs) at the upper end of the susceptible range for Staphylococcus aureus ( S. aureus ), as measured by the Etest method, have been associated with poor clinical outcomes of S. aureus bloodstream infections, as has the isolate’s genetic background....

Full description

Saved in:
Bibliographic Details
Published in:European journal of clinical microbiology & infectious diseases 2019-05, Vol.38 (5), p.903-912
Main Authors: Falcón, Rocío, Mateo, Eva, Oltra, Rosa, Giménez, Estela, Albert, Eliseo, Torres, Ignacio, Navarro, David
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c375t-e24f7601580c5e6c15e64e4a4355b76acf61020e74a8cbf7bc5473f42244da4b3
cites cdi_FETCH-LOGICAL-c375t-e24f7601580c5e6c15e64e4a4355b76acf61020e74a8cbf7bc5473f42244da4b3
container_end_page 912
container_issue 5
container_start_page 903
container_title European journal of clinical microbiology & infectious diseases
container_volume 38
creator Falcón, Rocío
Mateo, Eva
Oltra, Rosa
Giménez, Estela
Albert, Eliseo
Torres, Ignacio
Navarro, David
description Vancomycin (VAN) minimum inhibitory concentrations (MICs) at the upper end of the susceptible range for Staphylococcus aureus ( S. aureus ), as measured by the Etest method, have been associated with poor clinical outcomes of S. aureus bloodstream infections, as has the isolate’s genetic background. Here, we assessed the impact of VAN MICs, as determined by a broth microdilution method (BMD) that incorporates incremental VAN concentrations between the conventional log 2 dilutions, isolate susceptibility to killing by human phagocytes, acting as a surrogate marker for bacterial cell wall thickness, and S. aureus genetic composition, on the development of complicated S. aureus bacteremia (SAB). We carried out a retrospective, observational single-center cohort study of 148 consecutive patients with SAB caused by methicillin-susceptible (MSSA) isolates ( n  = 113) or methicillin-resistant (MRSA) isolates ( n  = 35). S. aureus isolates were genotyped using a commercially available DNA microarray. Overall, VAN MICs of S. aureus isolates taken from complicated and uncomplicated SAB were comparable, irrespective of the testing method ( P  = 0.19 with BMD, and P  = 0.94 with Etest). Likewise, S. aureus isolates in both comparison groups had the same susceptibility to killing by human phagocytes ( P =  0.5). Among the genes screened by the S. aureus DNA array, only Sec and Sel were differentially present among S. aureus isolates in both groups (overrepresented in those causing complications) and their presence was associated independently with complicated SAB in multivariate models adjusted for potentially relevant clinical covariates. Separate analysis of MSSA SAB episodes yielded similar results.
doi_str_mv 10.1007/s10096-019-03500-7
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2210232232</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2210232232</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-e24f7601580c5e6c15e64e4a4355b76acf61020e74a8cbf7bc5473f42244da4b3</originalsourceid><addsrcrecordid>eNp9kUtLxDAUhYMozjj6B1xIwI2baF5tpksZfAwoLnxsQ5rejtW2qUm76L8344wKLoRwE7jfObnJQeiY0XNGqboIsWYpoSwjVCSUErWDpkyKhEihxC6a0kxIkikuJugghDcaRXOl9tFEUMUzkaVTVLyY1rpmtFWL75eLgE1bYF-Fd-xKHBtdXVnTQ4FzY3vw0FQG5yNe1aN1HXR9VQAJQ7DrY14DfuxN9zrWzjprh-g2eBjCIdorTR3gaLvP0PP11dPiltw93CwXl3fECpX0BLgsVUpZMqc2gdSyWCRIE1-U5Co1tkwZ5RSUNHOblyq3iVSilJxLWRiZixk62_h23n0MEHrdVHG0ujYtuCFozqNe8LgievoHfXODb-N0mjOVJooyziLFN5T1LgQPpe581Rg_akb1OgO9yUDHDPRXBlpF0cnWesgbKH4k358eAbEBQmy1K_C_d_9j-wnXQpIH</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2176570121</pqid></control><display><type>article</type><title>Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus</title><source>Springer Nature</source><creator>Falcón, Rocío ; Mateo, Eva ; Oltra, Rosa ; Giménez, Estela ; Albert, Eliseo ; Torres, Ignacio ; Navarro, David</creator><creatorcontrib>Falcón, Rocío ; Mateo, Eva ; Oltra, Rosa ; Giménez, Estela ; Albert, Eliseo ; Torres, Ignacio ; Navarro, David</creatorcontrib><description>Vancomycin (VAN) minimum inhibitory concentrations (MICs) at the upper end of the susceptible range for Staphylococcus aureus ( S. aureus ), as measured by the Etest method, have been associated with poor clinical outcomes of S. aureus bloodstream infections, as has the isolate’s genetic background. Here, we assessed the impact of VAN MICs, as determined by a broth microdilution method (BMD) that incorporates incremental VAN concentrations between the conventional log 2 dilutions, isolate susceptibility to killing by human phagocytes, acting as a surrogate marker for bacterial cell wall thickness, and S. aureus genetic composition, on the development of complicated S. aureus bacteremia (SAB). We carried out a retrospective, observational single-center cohort study of 148 consecutive patients with SAB caused by methicillin-susceptible (MSSA) isolates ( n  = 113) or methicillin-resistant (MRSA) isolates ( n  = 35). S. aureus isolates were genotyped using a commercially available DNA microarray. Overall, VAN MICs of S. aureus isolates taken from complicated and uncomplicated SAB were comparable, irrespective of the testing method ( P  = 0.19 with BMD, and P  = 0.94 with Etest). Likewise, S. aureus isolates in both comparison groups had the same susceptibility to killing by human phagocytes ( P =  0.5). Among the genes screened by the S. aureus DNA array, only Sec and Sel were differentially present among S. aureus isolates in both groups (overrepresented in those causing complications) and their presence was associated independently with complicated SAB in multivariate models adjusted for potentially relevant clinical covariates. Separate analysis of MSSA SAB episodes yielded similar results.</description><identifier>ISSN: 0934-9723</identifier><identifier>EISSN: 1435-4373</identifier><identifier>DOI: 10.1007/s10096-019-03500-7</identifier><identifier>PMID: 30729396</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Antibiotics ; Bacteremia ; Biomedical and Life Sciences ; Biomedicine ; Cell walls ; Deoxyribonucleic acid ; DNA ; DNA chips ; DNA microarrays ; Drug resistance ; Internal Medicine ; Medical Microbiology ; Methicillin ; Original Article ; Pathogens ; Penicillin ; Phagocytes ; Staphylococcus aureus ; Test procedures ; Vancomycin ; Wall thickness</subject><ispartof>European journal of clinical microbiology &amp; infectious diseases, 2019-05, Vol.38 (5), p.903-912</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2019</rights><rights>European Journal of Clinical Microbiology &amp; Infectious Diseases is a copyright of Springer, (2019). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-e24f7601580c5e6c15e64e4a4355b76acf61020e74a8cbf7bc5473f42244da4b3</citedby><cites>FETCH-LOGICAL-c375t-e24f7601580c5e6c15e64e4a4355b76acf61020e74a8cbf7bc5473f42244da4b3</cites><orcidid>0000-0003-3010-4110</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30729396$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Falcón, Rocío</creatorcontrib><creatorcontrib>Mateo, Eva</creatorcontrib><creatorcontrib>Oltra, Rosa</creatorcontrib><creatorcontrib>Giménez, Estela</creatorcontrib><creatorcontrib>Albert, Eliseo</creatorcontrib><creatorcontrib>Torres, Ignacio</creatorcontrib><creatorcontrib>Navarro, David</creatorcontrib><title>Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus</title><title>European journal of clinical microbiology &amp; infectious diseases</title><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><description>Vancomycin (VAN) minimum inhibitory concentrations (MICs) at the upper end of the susceptible range for Staphylococcus aureus ( S. aureus ), as measured by the Etest method, have been associated with poor clinical outcomes of S. aureus bloodstream infections, as has the isolate’s genetic background. Here, we assessed the impact of VAN MICs, as determined by a broth microdilution method (BMD) that incorporates incremental VAN concentrations between the conventional log 2 dilutions, isolate susceptibility to killing by human phagocytes, acting as a surrogate marker for bacterial cell wall thickness, and S. aureus genetic composition, on the development of complicated S. aureus bacteremia (SAB). We carried out a retrospective, observational single-center cohort study of 148 consecutive patients with SAB caused by methicillin-susceptible (MSSA) isolates ( n  = 113) or methicillin-resistant (MRSA) isolates ( n  = 35). S. aureus isolates were genotyped using a commercially available DNA microarray. Overall, VAN MICs of S. aureus isolates taken from complicated and uncomplicated SAB were comparable, irrespective of the testing method ( P  = 0.19 with BMD, and P  = 0.94 with Etest). Likewise, S. aureus isolates in both comparison groups had the same susceptibility to killing by human phagocytes ( P =  0.5). Among the genes screened by the S. aureus DNA array, only Sec and Sel were differentially present among S. aureus isolates in both groups (overrepresented in those causing complications) and their presence was associated independently with complicated SAB in multivariate models adjusted for potentially relevant clinical covariates. Separate analysis of MSSA SAB episodes yielded similar results.</description><subject>Antibiotics</subject><subject>Bacteremia</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cell walls</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>DNA chips</subject><subject>DNA microarrays</subject><subject>Drug resistance</subject><subject>Internal Medicine</subject><subject>Medical Microbiology</subject><subject>Methicillin</subject><subject>Original Article</subject><subject>Pathogens</subject><subject>Penicillin</subject><subject>Phagocytes</subject><subject>Staphylococcus aureus</subject><subject>Test procedures</subject><subject>Vancomycin</subject><subject>Wall thickness</subject><issn>0934-9723</issn><issn>1435-4373</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kUtLxDAUhYMozjj6B1xIwI2baF5tpksZfAwoLnxsQ5rejtW2qUm76L8344wKLoRwE7jfObnJQeiY0XNGqboIsWYpoSwjVCSUErWDpkyKhEihxC6a0kxIkikuJugghDcaRXOl9tFEUMUzkaVTVLyY1rpmtFWL75eLgE1bYF-Fd-xKHBtdXVnTQ4FzY3vw0FQG5yNe1aN1HXR9VQAJQ7DrY14DfuxN9zrWzjprh-g2eBjCIdorTR3gaLvP0PP11dPiltw93CwXl3fECpX0BLgsVUpZMqc2gdSyWCRIE1-U5Co1tkwZ5RSUNHOblyq3iVSilJxLWRiZixk62_h23n0MEHrdVHG0ujYtuCFozqNe8LgievoHfXODb-N0mjOVJooyziLFN5T1LgQPpe581Rg_akb1OgO9yUDHDPRXBlpF0cnWesgbKH4k358eAbEBQmy1K_C_d_9j-wnXQpIH</recordid><startdate>20190501</startdate><enddate>20190501</enddate><creator>Falcón, Rocío</creator><creator>Mateo, Eva</creator><creator>Oltra, Rosa</creator><creator>Giménez, Estela</creator><creator>Albert, Eliseo</creator><creator>Torres, Ignacio</creator><creator>Navarro, David</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3010-4110</orcidid></search><sort><creationdate>20190501</creationdate><title>Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus</title><author>Falcón, Rocío ; Mateo, Eva ; Oltra, Rosa ; Giménez, Estela ; Albert, Eliseo ; Torres, Ignacio ; Navarro, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-e24f7601580c5e6c15e64e4a4355b76acf61020e74a8cbf7bc5473f42244da4b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Antibiotics</topic><topic>Bacteremia</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cell walls</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>DNA chips</topic><topic>DNA microarrays</topic><topic>Drug resistance</topic><topic>Internal Medicine</topic><topic>Medical Microbiology</topic><topic>Methicillin</topic><topic>Original Article</topic><topic>Pathogens</topic><topic>Penicillin</topic><topic>Phagocytes</topic><topic>Staphylococcus aureus</topic><topic>Test procedures</topic><topic>Vancomycin</topic><topic>Wall thickness</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Falcón, Rocío</creatorcontrib><creatorcontrib>Mateo, Eva</creatorcontrib><creatorcontrib>Oltra, Rosa</creatorcontrib><creatorcontrib>Giménez, Estela</creatorcontrib><creatorcontrib>Albert, Eliseo</creatorcontrib><creatorcontrib>Torres, Ignacio</creatorcontrib><creatorcontrib>Navarro, David</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of clinical microbiology &amp; infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Falcón, Rocío</au><au>Mateo, Eva</au><au>Oltra, Rosa</au><au>Giménez, Estela</au><au>Albert, Eliseo</au><au>Torres, Ignacio</au><au>Navarro, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus</atitle><jtitle>European journal of clinical microbiology &amp; infectious diseases</jtitle><stitle>Eur J Clin Microbiol Infect Dis</stitle><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><date>2019-05-01</date><risdate>2019</risdate><volume>38</volume><issue>5</issue><spage>903</spage><epage>912</epage><pages>903-912</pages><issn>0934-9723</issn><eissn>1435-4373</eissn><abstract>Vancomycin (VAN) minimum inhibitory concentrations (MICs) at the upper end of the susceptible range for Staphylococcus aureus ( S. aureus ), as measured by the Etest method, have been associated with poor clinical outcomes of S. aureus bloodstream infections, as has the isolate’s genetic background. Here, we assessed the impact of VAN MICs, as determined by a broth microdilution method (BMD) that incorporates incremental VAN concentrations between the conventional log 2 dilutions, isolate susceptibility to killing by human phagocytes, acting as a surrogate marker for bacterial cell wall thickness, and S. aureus genetic composition, on the development of complicated S. aureus bacteremia (SAB). We carried out a retrospective, observational single-center cohort study of 148 consecutive patients with SAB caused by methicillin-susceptible (MSSA) isolates ( n  = 113) or methicillin-resistant (MRSA) isolates ( n  = 35). S. aureus isolates were genotyped using a commercially available DNA microarray. Overall, VAN MICs of S. aureus isolates taken from complicated and uncomplicated SAB were comparable, irrespective of the testing method ( P  = 0.19 with BMD, and P  = 0.94 with Etest). Likewise, S. aureus isolates in both comparison groups had the same susceptibility to killing by human phagocytes ( P =  0.5). Among the genes screened by the S. aureus DNA array, only Sec and Sel were differentially present among S. aureus isolates in both groups (overrepresented in those causing complications) and their presence was associated independently with complicated SAB in multivariate models adjusted for potentially relevant clinical covariates. Separate analysis of MSSA SAB episodes yielded similar results.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>30729396</pmid><doi>10.1007/s10096-019-03500-7</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-3010-4110</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0934-9723
ispartof European journal of clinical microbiology & infectious diseases, 2019-05, Vol.38 (5), p.903-912
issn 0934-9723
1435-4373
language eng
recordid cdi_proquest_miscellaneous_2210232232
source Springer Nature
subjects Antibiotics
Bacteremia
Biomedical and Life Sciences
Biomedicine
Cell walls
Deoxyribonucleic acid
DNA
DNA chips
DNA microarrays
Drug resistance
Internal Medicine
Medical Microbiology
Methicillin
Original Article
Pathogens
Penicillin
Phagocytes
Staphylococcus aureus
Test procedures
Vancomycin
Wall thickness
title Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T15%3A43%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vancomycin%20MICs%20and%20risk%20of%20complicated%20bacteremia%20by%20glycopeptide-susceptible%20Staphylococcus%20aureus&rft.jtitle=European%20journal%20of%20clinical%20microbiology%20&%20infectious%20diseases&rft.au=Falc%C3%B3n,%20Roc%C3%ADo&rft.date=2019-05-01&rft.volume=38&rft.issue=5&rft.spage=903&rft.epage=912&rft.pages=903-912&rft.issn=0934-9723&rft.eissn=1435-4373&rft_id=info:doi/10.1007/s10096-019-03500-7&rft_dat=%3Cproquest_cross%3E2210232232%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c375t-e24f7601580c5e6c15e64e4a4355b76acf61020e74a8cbf7bc5473f42244da4b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2176570121&rft_id=info:pmid/30729396&rfr_iscdi=true